Cardiovascular risk prediction with cardio-ankle vascular index in the malaysian cohort study

Noraidatulakma Abdullah1, Joan Anak Blin1, Azwa Shawani Kamalul Arifin1

  • 1UKM Medical Molecular Biology Institute (UMBI), Kuala Lumpur 56000, Malaysia.

PubMed

Insights

High cardio-ankle vascular index (CAVI) scores predict cardiovascular disease (CVD) events in Malaysian adults. This study shows CAVI is an independent predictor of CVD risk and lower survival probability.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Public Health

Background:

  • The cardio-ankle vascular index (CAVI) assesses arterial stiffness and predicts cardiovascular disease (CVD) events.
  • Previous research suggests high CAVI is linked to increased CVD risk, but data from Malaysia were lacking.

Purpose of the Study:

  • To investigate the predictive value of CAVI for CVD events in a Malaysian population.
  • To determine if CAVI is an independent predictor of CVD incidence and mortality in the Malaysian Cohort (TMC).

Main Methods:

  • A prospective study of 2,168 CVD-free participants from The Malaysian Cohort (TMC) was conducted.
  • Participants were categorized by baseline CAVI scores (low: <9.0, high: ≥9.0) and followed for 7.5 years for CVD events.
  • Statistical analysis adjusted for factors including age, sex, ethnicity, and atherogenic index of plasma (AIP).

Main Results:

  • The incidence of CVD events was significantly higher in the high CAVI group (6.5%) compared to the low CAVI group (2.6%).
  • A CAVI cutoff of ≥9.0 independently predicted CVD events (adjusted OR = 1.78; 95% CI = 1.04–3.05).
  • Higher CAVI scores were associated with a significantly lower probability of survival.

Conclusions:

  • CAVI is a valuable, blood pressure-independent biomarker for assessing arterial stiffness.
  • This study demonstrates that CAVI is a significant independent predictor of future CVD events and mortality in the Malaysian population.
  • Routine CAVI measurement could aid in early CVD risk stratification and prevention strategies in Malaysia.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Assessing Blood pressure in the Leg01:11

Assessing Blood pressure in the Leg

Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
2.8K
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
721
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
608
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
171
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
345